Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors influencing neurological function changes after alteplase thrombolysis in acute cerebral infarction
ChiCTR2000034607Phase 4Recruiting
- Sponsor
- Department of Neurology, Shenzhen People's Hospital
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke and brain infarction, sponsored by Department of Neurology, Shenzhen People's Hospital. Primary endpoint: NIHSS score. Started Jun 2020; status: recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR2000034607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034607.